Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer

被引：0
|
作者：
Nakao, Masayuki [1 ]
Ichinose, Junji [1 ]
Matsuura, Yosuke [1 ]
Okumura, Sakae [1 ]
Mun, Mingyon [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 18期
关键词：
D O I：
10.21037/atm.2020.04.34
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Role of tyrosine phosphorylation of β-catenin in EGFR-mutant lung cancer
    Fujii, Masanori
    Nakayama, Sohei
    Shimizu, Kohei
    Takei, Hisashi
    Ando, Mariko
    Heo, Eunyoung
    Kobayashi, Ikei
    Pan, Gilbert
    Inuzuka, Hiroyuki
    Kobayashi, Susumu
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Afatinib—new therapy option for EGFR-mutant lung cancer
    Helena A. Yu
    William Pao
    Nature Reviews Clinical Oncology, 2013, 10 : 551 - 552
  • [23] Tackling the Next Generation of Resistance in EGFR-Mutant Lung Cancer
    Piotrowska, Zofia
    Sequist, Lecia V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 419 - 421
  • [24] Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer
    Lee, Jiyun
    Piotrowska, Zofia
    Soo, Ross
    Cho, Byoung Chul
    Lim, Sun Min
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [25] Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
    Ricciuti, Biagio
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S249 - S252
  • [26] One step too far in the right direction: The Society for Translational Medicine 2019 consensus on postoperative management of EGFR-mutant lung cancer
    Breadner, Daniel
    Raphael, Jacques
    JOURNAL OF THORACIC DISEASE, 2020, 12 (09) : 5046 - 5049
  • [27] Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition) (vol 8, pg 1163, 2019)
    Jiang, Gening
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 944 - 944
  • [28] Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR-mutant lung cancer
    Momcilovic, Milica
    Bailey, Sean T.
    Lee, Jason T.
    Magyar, Clara
    Braas, Daniel
    Graeber, Thomas
    Parlati, Francesco
    Demo, Susan
    Krysan, Konstyantyn
    Walser, Tonya C.
    Dubinett, Steven M.
    Sadeghi, Saman
    Christofk, Heather R.
    Shackelford, David B.
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [29] Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer
    Tricker, Erin M.
    Xu, Chunxiao
    Uddin, Sharmeen
    Capelletti, Marzia
    Ercan, Dalia
    Ogino, Atsuko
    Pratilas, Christine A.
    Rosen, Neal
    Gray, Nathanael S.
    Wong, Kwok-Kin
    Jaenne, Pasi A.
    CANCER DISCOVERY, 2015, 5 (09) : 960 - 971
  • [30] Optimizing the Sequence of Anti-EGFR-Targeted Therapy in EGFR-Mutant Lung Cancer
    Meador, Catherine B.
    Jin, Hailing
    de Stanchina, Elisa
    Nebhan, Caroline A.
    Pirazzoli, Valentina
    Wang, Lu
    Lu, Pengcheng
    Vuong, Huy
    Hutchinson, Katherine E.
    Jia, Peilin
    Chen, Xi
    Eisenberg, Rosana
    Ladanyi, Marc
    Politi, Katerina
    Zhao, Zhongming
    Lovly, Christine M.
    Cross, Darren A. E.
    Pao, William
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 542 - 552
12345